The persistence of very low correlations between NIH research funding and disease burdens

IF 2.2 Q2 PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH
Ashley J.R. Carter, Milena Gevorkian
{"title":"The persistence of very low correlations between NIH research funding and disease burdens","authors":"Ashley J.R. Carter,&nbsp;Milena Gevorkian","doi":"10.1016/j.puhip.2024.100580","DOIUrl":null,"url":null,"abstract":"<div><h3>Objectives</h3><div>The degree to which the allocation of disease-specific research funding by the NIH is proportional to disease burden is an important question. This study examined the historical relationship between NIH funding allocation and disease burden for a variety of medical conditions.</div></div><div><h3>Study design</h3><div>Coefficients of relatedness for the linear relationships between funding and disease burden for 27 medical conditions over a period exceeding twenty years were calculated.</div></div><div><h3>Methods</h3><div>Publicly available data from 2009 to 2019, and previously published data from 1994 to 2004, was obtained to compare disease-specific research funding from the NIH to burden of disease values (mortality, prevalence, incidence, DALYs, and YLLs) for 27 diseases.</div></div><div><h3>Results</h3><div>We identified very weak and declining correlations (e.g., R<sup>2</sup> &lt; 0.03) between funding and the five measures of burden for the 27 diseases. The weak relationships persist even when HIV/AIDS is omitted (e.g., R<sup>2</sup> &lt; 0.1). A recent decline in the overall strengths of the funding burden relationships is attributable to novel investment in Alzheimer's disease research.</div></div><div><h3>Conclusions</h3><div>The weak correlations reveal long-standing inefficiencies in the NIH disease funding allocation process. The recent increased and focused funding for Alzheimer's disease may not be justified by an objective analysis which considers disease burdens. Increased efficiency of medical research may be realized by improving the poor match between disease burden and funding allocation.</div></div>","PeriodicalId":34141,"journal":{"name":"Public Health in Practice","volume":"9 ","pages":"Article 100580"},"PeriodicalIF":2.2000,"publicationDate":"2024-12-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11754078/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Public Health in Practice","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S2666535224001174","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH","Score":null,"Total":0}
引用次数: 0

Abstract

Objectives

The degree to which the allocation of disease-specific research funding by the NIH is proportional to disease burden is an important question. This study examined the historical relationship between NIH funding allocation and disease burden for a variety of medical conditions.

Study design

Coefficients of relatedness for the linear relationships between funding and disease burden for 27 medical conditions over a period exceeding twenty years were calculated.

Methods

Publicly available data from 2009 to 2019, and previously published data from 1994 to 2004, was obtained to compare disease-specific research funding from the NIH to burden of disease values (mortality, prevalence, incidence, DALYs, and YLLs) for 27 diseases.

Results

We identified very weak and declining correlations (e.g., R2 < 0.03) between funding and the five measures of burden for the 27 diseases. The weak relationships persist even when HIV/AIDS is omitted (e.g., R2 < 0.1). A recent decline in the overall strengths of the funding burden relationships is attributable to novel investment in Alzheimer's disease research.

Conclusions

The weak correlations reveal long-standing inefficiencies in the NIH disease funding allocation process. The recent increased and focused funding for Alzheimer's disease may not be justified by an objective analysis which considers disease burdens. Increased efficiency of medical research may be realized by improving the poor match between disease burden and funding allocation.

Abstract Image

求助全文
约1分钟内获得全文 求助全文
来源期刊
Public Health in Practice
Public Health in Practice Medicine-Health Policy
CiteScore
2.80
自引率
0.00%
发文量
117
审稿时长
71 days
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信